Biogen (BIIB) Treasury Shares (2009 - 2026)

Biogen (BIIB) has reported Treasury Shares for 18 consecutive years, with $3.0 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares changed 0.0% year-over-year to $3.0 billion; the TTM figure through Mar 2026 stood at $3.0 billion (changed 0.0% YoY), while the FY2025 annual figure was $3.0 billion, changed 0.0% from the prior year.
• Treasury Shares came in at $3.0 billion for Q1 2026 at Biogen, roughly flat from $3.0 billion in the prior quarter.
• The five-year high for Treasury Shares was $23.8 million in Q4 2022, with the low at -$23.8 million in Q1 2022.
• Average Treasury Shares over 5 years is -$13.3 million, with a median of -$23.8 million recorded in 2022.
• The largest YoY upside for Treasury Shares was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
• Year by year, Treasury Shares stood at $3.0 billion in 2022, then changed by 0.0% to $3.0 billion in 2023, then changed by 0.0% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025, then changed by 0.0% to $3.0 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $3.0 billion, $3.0 billion, and $3.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.